{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:28:27Z","timestamp":1778624907311,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20 K15682"],"award-info":[{"award-number":["20 K15682"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Veterinary Science"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.rvsc.2022.11.003","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T20:27:04Z","timestamp":1668198424000},"page":"22-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Assessment of hypoxia-targeting therapy for gastrointestinal lymphoma in dogs: Preclinical test using murine models"],"prefix":"10.1016","volume":"154","author":[{"given":"Hiroki","family":"Yamazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetaka","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Hatoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Akiyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rvsc.2022.11.003_bb0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11060-008-9697-z","article-title":"What is the translational efficacy of chemotherapeutic drug research in neuro-oncology? A systematic review and meta-analysis of the efficacy of BCNU and CCNU in animal models of glioma","volume":"91","author":"Amarasingh","year":"2009","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.rvsc.2022.11.003_bb0010","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/ajh.24415","article-title":"Phase I study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemia","volume":"91","author":"Badar","year":"2016","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.rvsc.2022.11.003_bb0015","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1158\/1078-0432.CCR-12-2123","article-title":"Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer","volume":"19","author":"Brauer","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.rvsc.2022.11.003_bb0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrclinonc.2015.53","article-title":"Pancreatic cancer: from state-of-the-art treatments to promising novel therapies","volume":"12","author":"Garrido-Laguna","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.rvsc.2022.11.003_bb0025","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3390\/ijms22041805","article-title":"Differences in the central energy metabolism of cancer cells between conventional 2D and novel 3D culture systems","volume":"22","author":"Ikari","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.rvsc.2022.11.003_bb0030","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3109\/00498254.2011.650234","article-title":"Metabolism and excretion of TH-302 in dogs","volume":"42","author":"Jung","year":"2012","journal-title":"Xenobiotica."},{"key":"10.1016\/j.rvsc.2022.11.003_bb0035","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/00498254.2011.622810","article-title":"Metabolism, pharmacokinetics and excretion of a novel hypoxia activated cytotoxic prodrug, TH-302, in rats","volume":"42","author":"Jung","year":"2012","journal-title":"Xenobiotica."},{"key":"10.1016\/j.rvsc.2022.11.003_bb0040","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1292\/jvms.15-0258","article-title":"Hypoxia inducible factor 1\u03b1 expression and effects of its inhibitors in canine lymphoma","volume":"77","author":"Kambayashi","year":"2015","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.rvsc.2022.11.003_bb0045","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3109\/10428194.2014.963575","article-title":"Glycolytic inhibitor 2-deoxy-d-glucose suppresses cell proliferation and enhances methylprednisolone sensitivity in non-Hodgkin lymphoma cells through down-regulation of HIF-1\u03b1 and c-MYC","volume":"56","author":"Pang","year":"2015","journal-title":"Leuk. Lymphoma."},{"key":"10.1016\/j.rvsc.2022.11.003_bb0050","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00280-015-2920-7","article-title":"Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs","volume":"77","author":"Phillips","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.rvsc.2022.11.003_bb0055","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.1158\/1078-0432.CCR-13-0674","article-title":"Activity of the hypoxia-activated prodrug, TH-302, in preclinical human acute myeloid leukemia models","volume":"19","author":"Portwood","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.rvsc.2022.11.003_bb0060","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.mayocpiqo.2021.01.012","article-title":"Elevated serum lactate in patients with lymphoma: it is not always infection","volume":"5","author":"Ruan","year":"2021","journal-title":"Mayo Clin. Proc. Innov. Qual. Outcomes."},{"key":"10.1016\/j.rvsc.2022.11.003_bb0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10585-010-9360-x","article-title":"Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by hypoxia-inducible factor-1\u03b1","volume":"28","author":"Schelter","year":"2011","journal-title":"Clin. Exp. Metastasis."},{"key":"10.1016\/j.rvsc.2022.11.003_bb0070","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2460\/javma.252.4.440","article-title":"Intestinal lymphoma in dogs: 84 cases (1997\u20132012)","volume":"252","author":"Sogame","year":"2018","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.rvsc.2022.11.003_bb0075","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1158\/1078-0432.CCR-11-1980","article-title":"Selective tumor hypoxia targeting by hypoxia-activated prodrug TH-302 inhibits tumor growth in preclinical models of cancer","volume":"18","author":"Sun","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.rvsc.2022.11.003_bb0080","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0002-9440(10)64554-3","article-title":"The expression and distribution of the hypoxia-inducible factors HIF-1 alpha and HIF-2 alpha in normal human tissues, cancers, and tumor-associated macrophages","volume":"157","author":"Talks","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.rvsc.2022.11.003_bb0090","doi-asserted-by":"crossref","first-page":"e5990","DOI":"10.1073\/pnas.1801348115","article-title":"Hypoxic tumor microenvironment activates GLI2 via HIF-1\u03b1 and TGF-\u03b22 to promote chemoresistance in colorectal cancer","volume":"115","author":"Tang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.rvsc.2022.11.003_bb0095","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1292\/jvms.12-0448","article-title":"Establishment of five canine lymphoma cell lines and tumor formation in a xenotransplantation model","volume":"75","author":"Umeki","year":"2013","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.rvsc.2022.11.003_bb0100","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/exd.14133","article-title":"Systemic chemotherapy promotes HIF-1 alpha-mediated glycolysis and IL-17F pathways in cutaneous T-cell lymphoma","volume":"29","author":"Wang","year":"2020","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.rvsc.2022.11.003_bb0105","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1158\/1078-0432.CCR-10-3425","article-title":"Phase 1 study of the safety, tolerability, and pharmacokinetics of TH-302, a hypoxia-activated prodrug, in patients with advanced solid malignancies","volume":"17","author":"Weiss","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.rvsc.2022.11.003_bb0110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejmech.2012.01.033","article-title":"Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors","volume":"49","author":"Xia","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.rvsc.2022.11.003_bb0115","series-title":"Da. Xue. Bao Yi Xue Xue Ban","first-page":"219","article-title":"Effects of aerobic glycolysis on pathogenesis and drug resistance of non-Hodgkin lymphoma. Zhejiang Da Xue Xue Bao Yi Xue ban. 48, 219\u2013223","volume":"48","author":"Xu","year":"2019"},{"key":"10.1016\/j.rvsc.2022.11.003_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177305","article-title":"Hypoxia-activated prodrug TH-302 decreased survival rate of canine lymphoma cells under hypoxic condition","volume":"12","author":"Yamazaki","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.rvsc.2022.11.003_bb0125","article-title":"Hypoxia-targeting therapy for intestinal T-cell lymphoma in dogs: Preclinical study using 3D in vitro models","author":"Yamazaki","year":"2022","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.rvsc.2022.11.003_bb0130","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1002\/cam4.1551","article-title":"FM19G11 inhibits O (6)-methylguanine DNA-methyltransferase expression under both hypoxic and normoxic conditions","volume":"7","author":"You","year":"2018","journal-title":"Cancer Med."}],"container-title":["Research in Veterinary Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528822003605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528822003605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:55:18Z","timestamp":1778622918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034528822003605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":25,"alternative-id":["S0034528822003605"],"URL":"https:\/\/doi.org\/10.1016\/j.rvsc.2022.11.003","relation":{},"ISSN":["0034-5288"],"issn-type":[{"value":"0034-5288","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of hypoxia-targeting therapy for gastrointestinal lymphoma in dogs: Preclinical test using murine models","name":"articletitle","label":"Article Title"},{"value":"Research in Veterinary Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rvsc.2022.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}